IONIS PHARMACEUTICALS INC

HTTP://WWW.LIVINGBRIDGE.COM CARLSBAD, CA Investment Advisor How do I update this listing?

Ionis Pharmaceuticals is based out of Carlsbad. Ionis Pharmaceuticals is a registered investment advisory firm with discretionary assets under management (AUM) of $0 (Form ADV from 2021-03-30).Isis Pharmaceuticals focuses on RNA-based drug discovery technologies to identify and commercialize novel drugs to treat diseases. The antisense technology allows for the creation of inhibitors designed to bind (with high specificity) to their RNA target and modulate protein production.Whalewisdom has at least 11 13D filings, and 348 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2012-08-27. The notice included securities offered of Debt

Create Alert

Contact Info

ionis pharmaceuticals inc
2855 GAZELLE COURT
CARLSBAD CA    92010

Business Phone: 7609319200
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS
Current 13D/G Holdings
Stock Sector Shares Held Market Value Rank Source Source Date
Regulus Therapeutics Inc (RGLS) HEALTH CARE 236,836 2,047,083.84 1 13D 2015-07-22
Akcea Therapeutics Inc (AKCA) HEALTH CARE 1,000 18,170.00 2 13D 2020-10-10

View Last Form Adv Compilation Report on Record

LIVINGBRIDGE EP LLP
100 WOOD STREET
LONDON    EC2V 7AN
Country: United Kingdom

Business Phone: 44 0 20 7506 5600
Fax: 44 0 20 7506 5750
Professional Investment Advisor Data
SEC Registration as :
Form of Organization: Other (specify) INCORPORATED ENTITY ORGANIZED UNDER ENGLISH LAW.
Organized in:
Number of employees:
Other Business Activities:
Advisor Fees/Compensation:
Amount of client funds and securities:
Total Number of Clients: 0
Amount of client funds and securities by related persons:
Total Number of clients from related persons:
Disclosures:
Data above was derived from SEC filings.

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2012-08-27 D PHARMACEUTICALS Debt 201,250,000 201,250,000 0
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
B LYNNE PARSHALL subscription required
    EXECUTIVE OFFICER DIRECTOR
BRETT P MONIA subscription required
    EXECUTIVE OFFICER
C FRANK BENNETT subscription required
    EXECUTIVE OFFICER
FREDERICK T MUTO subscription required
    DIRECTOR
JOHN C REED subscription required
    DIRECTOR
JOSEPH KLEIN III subscription required
    DIRECTOR
JOSEPH H WENDER subscription required
    DIRECTOR
RICHARD S GEARY subscription required
    EXECUTIVE OFFICER
SPENCER R BERTHELSEN subscription required
    DIRECTOR
STANLEY T CROOKE subscription required
    EXECUTIVE OFFICER DIRECTOR

Elevate your investments